{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:55:27Z","timestamp":1780376127441,"version":"3.54.1"},"reference-count":112,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Angiotensinogen (AGT) and aldosterone play key roles in the regulation of blood pressure and are implicated in the pathogenesis of cardiovascular diseases. DNA methylation typically acts to repress gene transcription. The aldosterone synthase gene CYP11B2 is regulated by angiotensin II and potassium. DNA methylation negatively regulates AGT and CYP11B2 expression and dynamically changes in response to continuous promoter stimulation of each gene. High salt intake and excess circulating aldosterone cause DNA demethylation around the CCAAT-enhancer-binding-protein (CEBP) sites of the ATG promoter region, thereby converting the phenotype of AGT expression from an inactive to an active state in visceral adipose tissue and heart. A close association exists between low DNA methylation at CEBP-binding sites and increased AGT expression in salt-sensitive hypertensive rats. Salt-dependent hypertension may be partially affected by increased cardiac AGT expression. CpG dinucleotides in the CYP11B2 promoter are hypomethylated in aldosterone-producing adenomas. Methylation of recognition sequences of transcription factors, including CREB1, NGFIB (NR4A1), and NURR1 (NR4A2) diminish their DNA-binding activity. The methylated CpG-binding protein MECP2 interacts directly with the methylated CYP11B2 promoter. Low salt intake and angiotensin II infusion lead to upregulation of CYP11B2 expression and DNA hypomethylation in the adrenal gland. Treatment with the angiotensin II type 1 receptor antagonist decreases CYP11B2 expression and leads to DNA hypermethylation. A close association between low DNA methylation and increased CYP11B2 expression are seen in the hearts of patients with hypertrophic cardiomyopathy. These results indicate that epigenetic regulation of both AGT and CYP11B2 contribute to the pathogenesis of cardiovascular diseases.<\/jats:p>","DOI":"10.3390\/ijms22094587","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T21:18:20Z","timestamp":1619558300000},"page":"4587","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["DNA Methylation of the Angiotensinogen Gene, AGT, and the Aldosterone Synthase Gene, CYP11B2 in Cardiovascular Diseases"],"prefix":"10.3390","volume":"22","author":[{"given":"Yoshimichi","family":"Takeda","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanazawa University Hospital, Kanazawa 920-8641, Japan"},{"name":"Department of Hygiene, Graduate School of Medical Science, Kanazawa University, Kanazawa 920-8641, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Demura","sequence":"additional","affiliation":[{"name":"Department of Hygiene, Graduate School of Medical Science, Kanazawa University, Kanazawa 920-8641, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0921-158X","authenticated-orcid":false,"given":"Takashi","family":"Yoneda","sequence":"additional","affiliation":[{"name":"Institute of Liberal Arts and Science, Kanazawa University, Kanazawa 920-8641, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyu","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanazawa University Hospital, Kanazawa 920-8641, Japan"},{"name":"Endocrine and Diabetes Center, Asanogawa General Hospital, Kanazawa 920-8621, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41569-019-0244-8","article-title":"Counter-regulatory renin-angiotensin system in cardiovascular disease","volume":"17","author":"Riquelme","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Azushima, K., Morisawa, N., Tamura, K., and Nishiyama, A. (2020). Recent research advances in renin-angiotensin-aldosterone system receptors. Curr. Hypertens. Rep., 22.","DOI":"10.1007\/s11906-020-1028-6"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jvim.15454","article-title":"The renin-angiotensin-aldosterone system and its suppression","volume":"33","author":"Ames","year":"2019","journal-title":"Vet. Intern. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/HYPERTENSIONAHA.115.07074","article-title":"Aldosterone-induced vascular remodeling and endothelial dysfunction require functional angiotensin type 1a receptors","volume":"67","author":"Briet","year":"2016","journal-title":"Hypertension"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.phrs.2017.05.020","article-title":"Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease","volume":"125","author":"Ferrario","year":"2017","journal-title":"Pharmacol. Res."},{"key":"ref_6","first-page":"e14105","article-title":"Both aldosterone and spironolactone can modulate the intracellular ACE\/ANG II\/AT1 and ACE2\/ANG (1-7)\/MAS receptor axes in human mesangial cells","volume":"11","author":"Stoll","year":"2019","journal-title":"Physiol. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10286-018-0572-5","article-title":"The renin-angiotensin system in cardiovascular autonomic control: Recent developments and clinical implications","volume":"29","author":"Miller","year":"2019","journal-title":"Clin. Auton. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejps.2018.11.037","article-title":"Sacubitril\/valsartan (LCZ696) significantly reduces aldosterone and increases cGMP circulating levels in a canine model of RAAS activation","volume":"128","author":"Mochel","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3892\/br.2013.74","article-title":"Effects of aging and uninephrectomy on renal changes in Tsukuba hypertensive mice","volume":"1","author":"Inui","year":"2013","journal-title":"Biomed. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/HJH.0b013e328325d861","article-title":"Effect of mineralocorticoid receptor blockade on the renal renin-angiotensin system in Dahl salt-sensitive hypertensive rats","volume":"27","author":"Zhu","year":"2009","journal-title":"J. Hypertens."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1096\/fj.01-0457fje","article-title":"Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation","volume":"15","author":"Massiera","year":"2001","journal-title":"FASEB J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/oby.2011.299","article-title":"Overproduction of angiotensinogen from adipose tissue induces adipose inflammation, glucose Intolerance, and insulin resistance","volume":"20","author":"Kalupahana","year":"2012","journal-title":"Obesity"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/ajh.2009.263","article-title":"Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: Impact of nutritional status and adipocyte hypertrophy","volume":"23","author":"Yasue","year":"2010","journal-title":"Am. J. Hypertens."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"H989","DOI":"10.1152\/ajpheart.00073.2018","article-title":"New roles of aldosterone and mineralocorticoid receptors in cardiovascular disease: Translational and sex-specific effects","volume":"315","author":"Davel","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/hc0602.104675","article-title":"Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy","volume":"105","author":"Takeda","year":"2002","journal-title":"Circulation"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11886-020-01399-7","article-title":"Mineralocorticoid receptor antagonists: A comprehensive review of finerenone","volume":"22","author":"White","year":"2020","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40620-019-00600-7","article-title":"New mineralocorticoid receptor antagonists: Update on their use in chronic kidney disease and heart failure","volume":"33","author":"Capelli","year":"2020","journal-title":"J. Nephrol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1161\/HYPERTENSIONAHA.117.10263","article-title":"Prevalence of cardiovascular disease and its risk factors in primary aldosteronism: A multicenter study in Japan","volume":"71","author":"Ohno","year":"2018","journal-title":"Hypertension"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41574-020-0382-4","article-title":"Pathogenesis and treatment of primary aldosteronism","volume":"16","author":"Zennaro","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1210\/clinem\/dgaa606","article-title":"Evolution of the primary aldosteronism syndrome: Updating the approach","volume":"105","author":"Vaidya","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"101365","DOI":"10.1016\/j.beem.2019.101365","article-title":"Prevalence, diagnosis and outcomes of treatment for primary aldosteronism","volume":"34","author":"Yang","year":"2020","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/CRD.0000000000000281","article-title":"Primary aldosteronism: Cardiovascular risk, diagnosis, and management","volume":"28","author":"Pillai","year":"2020","journal-title":"Cardiol. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41440-020-0468-3","article-title":"Management of primary aldosteronism and mineralocorticoid receptor-associated hypertension","volume":"43","author":"Morimoto","year":"2020","journal-title":"Hypertens. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"T125","DOI":"10.1530\/JOE-16-0600","article-title":"30 Years of the mineralocorticoid receptor: Mineralocorticoid receptor antagonists: 60 years of research and development","volume":"234","author":"Kolkhof","year":"2017","journal-title":"J. Endocrinol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/HYPERTENSIONAHA.119.14057","article-title":"Medical therapies for heart failure with preserved ejection fraction","volume":"75","author":"Kjeldsen","year":"2020","journal-title":"Hypertension"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Pandey, A., Garg, S., Matulevicius, S.A., Shah, A.M., Garg, J., Drazner, M.H., Amin, A., Berry, J.D., Marwick, T.H., and Marso, S.P. (2015). Effect of mineralocorticoid receptor antagonists on cardiac structure and function in patients with diastolic dysfunction and heart failure with preserved ejection fraction: A meta-analysis and systematic review. J. Am. Heart Assoc., 4.","DOI":"10.1161\/JAHA.115.002137"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1139\/cjpp-2020-0276","article-title":"The role of aldosterone inhibitors in cardiac ischemia-reperfusion injury","volume":"99","author":"Dragasevic","year":"2021","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4103\/JPBS.JPBS_338_19","article-title":"Eplerenone: The multifaceted drug in cardiovascular pharmacology","volume":"12","author":"Pradhan","year":"2020","journal-title":"J. Pharm. Bioallied. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.amjhyper.2007.05.008","article-title":"Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats","volume":"10","author":"Takeda","year":"2007","journal-title":"Am. J. Hypertens."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"H1802","DOI":"10.1152\/ajpheart.01096.2001","article-title":"Aldosterone induces a vascular inflammatory phenotype in the rat heart","volume":"283","author":"Rocha","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fgene.2020.00171","article-title":"DNA methylation biomarkers in aging and age-related diseases","volume":"11","author":"Salameh","year":"2020","journal-title":"Front. Genet."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jid.2019.05.011","article-title":"DNA methylation in epidermal differentiation, aging, and cancer","volume":"140","year":"2020","journal-title":"J. Investig. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1161\/HYPERTENSIONAHA.118.11171","article-title":"Epigenetic mechanisms and hypertension","volume":"72","author":"Liang","year":"2018","journal-title":"Hypertension"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/hr.2015.42","article-title":"Dynamic regulation of the angiotensinogen gene by DNA methylation, which is influenced by various stimuli experienced in daily life","volume":"38","author":"Demura","year":"2015","journal-title":"Hypertens. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41576-020-00287-8","article-title":"Active turnover of DNA methylation during cell fate decisions","volume":"22","author":"Parry","year":"2021","journal-title":"Nat. Rev. Genet."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/HYPERTENSIONAHA.113.02303","article-title":"Dynamic CCAAT\/enhancer binding protein-associated changes of DNA methylation in the angiotensinogen gene","volume":"63","author":"Wang","year":"2014","journal-title":"Hypertension"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11906-020-01113-6","article-title":"Female sex, a major risk factor for salt-sensitive hypertension","volume":"22","author":"Faulkner","year":"2020","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.amjmed.2019.07.034","article-title":"Salt, no salt, or less salt for patients with heart failure?","volume":"133","author":"Khan","year":"2020","journal-title":"Am. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/advances\/nmz134","article-title":"A systematic review of the sources of dietary salt around the world","volume":"11","author":"Bhat","year":"2020","journal-title":"Adv. Nutr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"m315","DOI":"10.1136\/bmj.m315","article-title":"Effect of dose and duration of reduction in dietary sodium on blood pressure levels: Systematic review and meta-analysis of randomised trials","volume":"368","author":"Huang","year":"2020","journal-title":"BMJ"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Grillo, A., Salvi, L., Coruzzi, P., Salvi, P., and Parati, G. (2019). Sodium intake and hypertension. Nutrients, 11.","DOI":"10.3390\/nu11091970"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jacc.2019.11.055","article-title":"Salt reduction to prevent hypertension and cardiovascular disease: JACC state-of-the-art review","volume":"75","author":"He","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s10157-018-1567-1","article-title":"Independent regulation of renin\u2013angiotensin\u2013aldosterone system in the kidney","volume":"22","author":"Nishiyama","year":"2018","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1161\/HYPERTENSIONAHA.118.11303","article-title":"Lack of suppression of aldosterone production leads to salt sensitive hypertension in female but not male Balb\/C mice","volume":"72","author":"Faulkner","year":"2018","journal-title":"Hypertension"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41598-017-00461-9","article-title":"Salt-dependent blood pressure in human aldosterone synthase-transgenic mice","volume":"7","author":"Gu","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"H1795","DOI":"10.1152\/ajpheart.01023.2011","article-title":"Differential effects of high-fat diet on myocardial lipid metabolism in failing and nonfailing hearts with angiotensin II-mediated cardiac remodeling in mice","volume":"302","author":"Pellieux","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41440-020-0458-5","article-title":"Impact of mineralocorticoid receptor blockade with direct renin inhibition in angiotensin II-dependent hypertensive mice","volume":"43","author":"Hashimoto","year":"2020","journal-title":"Hypertens. Res."},{"key":"ref_48","first-page":"1753","article-title":"Effect of prehypertensive losartan therapy on AT1R and ATRAP methylation of adipose tissue in the later life of high-fat-fed spontaneously hypertensive rats","volume":"17","author":"Wang","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/cvr\/cvt264","article-title":"Inhibition of DNA methylation reverses norepinephrine-induced cardiac hypertrophy in rats","volume":"101","author":"Xiao","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1210\/er.2018-00139","article-title":"The expanding spectrum of primary aldosteronism: Implications for diagnosis, pathogenesis, and treatment","volume":"39","author":"Vaidya","year":"2018","journal-title":"Endocr. Rev."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1530\/EJE-15-0450","article-title":"Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn\u2019s Registry","volume":"173","author":"Hanslik","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2337\/dc18-1293","article-title":"High prevalence of diabetes in patients with primary aldosteronism (PA) associated withsubclinical hypercortisolism and prediabetes more prevalent in bilateral than unilateral PA: A large, multicenter cohort study in Japan","volume":"42","author":"Akehi","year":"2019","journal-title":"Diabetes Care."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/21623945.2019.1690834","article-title":"Increased oxidative stress, inflammation and fibrosis in perirenal adipose tissue of patients with aldosterone-producing adenoma","volume":"8","author":"Wu","year":"2019","journal-title":"Adipocyte"},{"key":"ref_54","first-page":"2797","article-title":"Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin","volume":"81","author":"Takeda","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1038\/s41467-020-15408-4","article-title":"Angiotensin II induces coordinated calcium bursts in aldosterone-producing adrenal rosettes","volume":"11","author":"Guagliardo","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/bph.14630","article-title":"Novel molecular mechanisms in the inhibition of adrenal aldosterone synthesis: Action of tolvaptan via vasopressin V2 receptor-independent pathway","volume":"176","author":"Ali","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1042\/CS20171593","article-title":"The angiotensin type 2 receptor in the human adrenocortical zona glomerulosa and in aldosterone-producing adenoma: Low expression and no functional role","volume":"132","author":"Vanderriele","year":"2018","journal-title":"Clin. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1042\/CS20171285","article-title":"Targeted disruption of the Kcnj5 gene in the female mouse lowers aldosterone levels","volume":"132","author":"Hardege","year":"2018","journal-title":"Clin. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.1152\/ajpendo.00454.2005","article-title":"StAR expression and the long-term aldosterone response to high-potassium diet in Wistar-Kyoto and spontaneously hypertensive rats","volume":"292","author":"Peters","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/HJH.0b013e32834626bb","article-title":"Multiple noncoding exons 1 of nuclear receptors NR4A family (nerve growth factor-induced clone B, Nur-related factor 1 and neuron-derived orphan receptor 1) and NR5A1 (steroidogenic factor 1) in human cardiovascular and adrenal tissues","volume":"29","author":"Demura","year":"2011","journal-title":"J. Hypertens."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1677\/JME-09-0171","article-title":"Identification of adrenal genes regulated in a potassium-dependent manner","volume":"45","author":"Dierks","year":"2010","journal-title":"J. Mol. Endocrinol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Takeda, Y., Demura, M., Wang, F., Karashima, S., Yoneda, T., Kometani, M., Aomo, D., Hashimoto, A., Horike, S., and Meguro-Horike, M. (2021). Effect of potassium on DNA methylation of aldosterone synthase gene. J. Hypertens.","DOI":"10.1097\/HJH.0000000000002742"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Takeda, Y., Demura, M., Wang, F., Karashima, S., Yoneda, T., Kometani, M., Hashimoto, A., Aono, D., Horike, S., and Meguro-Horike, M. (2018). Epigenetic regulation of aldosterone synthase gene by sodium and angiotensin I.I. J. Am. Heart Assoc., 7.","DOI":"10.1161\/JAHA.117.008281"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1210\/jc.2004-0069","article-title":"Nur-related factor 1 and nerve growth factor-induced clone B in human adrenal cortex and its disorders","volume":"89","author":"Lu","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1677\/JME-07-0094","article-title":"Angiotensin-II acute regulation of rapid response genes in human, bovine, and rat adrenocortical cells","volume":"39","author":"Nogueira","year":"2007","journal-title":"J. Mol. Endocrinol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1210\/en.2013-1999","article-title":"Sodium deficiency regulates rat adrenal zona glomerulosa gene expression","volume":"155","author":"Nishimoto","year":"2014","journal-title":"Endocrinology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1016\/j.jacc.2019.03.508","article-title":"No aldosterone breakthrough with the neprilysin inhibitor sacubitril","volume":"73","author":"Vergaro","year":"2019","journal-title":"Am. Coll. Cardiol."},{"key":"ref_68","first-page":"34","article-title":"New evidence supporting the use of mineralocorticoid receptor blockers in drug-resistant hypertension","volume":"5","author":"Webb","year":"2016","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2174\/1574884713666181116100946","article-title":"The ascent of mineralocorticoid receptor antagonists in diabetic nephropathy","volume":"14","author":"Goenka","year":"2019","journal-title":"Curr. Clin. Pharmacol."},{"key":"ref_70","first-page":"486","article-title":"The incidence and implications of aldosterone breakthrough","volume":"3","author":"Bomback","year":"2007","journal-title":"Nephrology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"594","DOI":"10.2174\/157016111796642689","article-title":"Aldosterone, from (patho)physiology to treatment in cardiovascular and renal damage","volume":"9","author":"Waanders","year":"2011","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/ajh\/hpw003","article-title":"The role of aldosterone on obesity-related hypertension","volume":"29","author":"Kawarazaki","year":"2016","journal-title":"Am. J. Hypertens."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Di Dalmazi, G., Morandi, L., Rubin, B., Pilon, C., Asioli, S., Vicennati, V., De Leo, A., Ambrosi, F., Santini, D., and Pagotto, U. (2020). DNA methylation of steroidogenic enzymes in benign adrenocortical tumors: New insights in aldosterone-producing adenomas. J. Clin. Endocrinol. Metab., 105.","DOI":"10.1210\/clinem\/dgaa585"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"E536","DOI":"10.1210\/jc.2013-3495","article-title":"Integrated analysis of genome-wide methylation and gene expression shows epigenetic regulation of CYP11B2 in aldosteronomas","volume":"99","author":"Howard","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/HYPERTENSIONAHA.116.08313","article-title":"Hypomethylation of CYP11B2 in aldosterone-producing adenoma","volume":"68","author":"Yoshii","year":"2016","journal-title":"Hypertension"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1210\/jc.2015-3285","article-title":"Case report: Nodule development from subcapsular aldosterone producing cell clusters causes hyperaldosteronism","volume":"101","author":"Nishimoto","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1055\/a-1128-0421","article-title":"The potential role of aldosterone-producing cell clusters in adrenal disease","volume":"52","author":"Lim","year":"2020","journal-title":"Horm. Metab. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1161\/HYPERTENSIONAHA.119.14177","article-title":"Genetic, cellular, and molecular heterogeneity in adrenals with aldosterone-producing adenoma","volume":"75","author":"Boulkroun","year":"2020","journal-title":"Hypertension"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/js.2017-00134","article-title":"Aldosterone-producing cell clusters frequently harbor somatic mutations and accumulate with age in mormal adrenals","volume":"1","author":"Omata","year":"2017","journal-title":"J. Endocr. Soc."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/HYPERTENSIONAHA.119.14041","article-title":"Mass spectrometry imaging establishes 2 distinct metabolic phenotypes of aldosterone-producing cell clusters in primary aldosteronism","volume":"75","author":"Sun","year":"2020","journal-title":"Hypertension"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1016\/j.jacc.2019.09.057","article-title":"Primary aldosteronism: JACC state-of-the-art review","volume":"74","author":"Rossi","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11906-020-1023-y","article-title":"Mineralocorticoid receptor blockers: Novel selective nonsteroidal mineralocorticoid receptor antagonists","volume":"22","author":"Sueta","year":"2020","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1161\/HYPERTENSIONAHA.107.096925","article-title":"Spontaneous resolution of idiopathic aldosteronism after long-term treatment with potassium canrenoate","volume":"50","author":"Armanini","year":"2007","journal-title":"Hypertension"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2265.2011.04243.x","article-title":"Spontaneous remission of idiopathic aldosteronism after long-term treatment with spironolactone: Results from the German Conn\u2019s Registry","volume":"76","author":"Fischer","year":"2012","journal-title":"Clin. Endocrinol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1530\/EJE-12-0912","article-title":"Long-term re-evaluation of primary aldosteronism after medical treatment reveals high proportion of normal mineralocorticoid secretion","volume":"168","author":"Lucatello","year":"2013","journal-title":"Eur. J. Endocrinol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1210\/jc.2011-2563","article-title":"Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy","volume":"97","author":"Yoneda","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-0028-1087188","article-title":"Contrasting effects of eplerenone and spironolactone on adrenal cell steroidogennesis","volume":"41","author":"Ye","year":"2009","journal-title":"Horm. Metab. Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/ejhf.541","article-title":"Pharmacological treatment of hypertrophic cardiomyopathy: Current practice and novel perspectives","volume":"18","author":"Ammirati","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical course and management of hypertrophic cardiomyopathy","volume":"379","author":"Maron","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jchf.2018.02.010","article-title":"Hypertrophic cardiomyopathy: Clinical update","volume":"6","author":"Geske","year":"2018","journal-title":"JACC Heart Fail."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1253\/circj.CJ-20-0524","article-title":"Hypertrophic cardiomyopathy\u2014A heterogeneous and lifelong disease in the real world","volume":"84","author":"Kitaoka","year":"2020","journal-title":"Circ. J."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ejhf.1715","article-title":"Hypertrophic cardiomyopathy: The future of treatment","volume":"F22","author":"Tuohy","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1136\/heartjnl-2017-312573","article-title":"Renin-angiotensin-aldosterone blockade reduces atrial fibrillation in hypertorphic cardiomyopathy","volume":"104","author":"Huang","year":"2018","journal-title":"Heart"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Alexandre, J., Dolladille, C., Douesnel, L., Font, J., Dabrowski, R., Shavit, L., Legallois, D., Funck-Brentano, C., Champ-Rigot, L., and Ollitrault, P. (2019). Effects of Mineralocorticoid Receptor Antagonists on Atrial Fibrillation Occurrence: A systematic review, meta-analysis, and meta-regression to identify modifying factors. Am. Heart Assoc., 8.","DOI":"10.1161\/JAHA.119.013267"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/01.CIR.0000121426.43044.2B","article-title":"Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy","volume":"109","author":"Tsybouleva","year":"2009","journal-title":"Circulation"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrneph.2013.110","article-title":"Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis","volume":"9","author":"Brown","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_97","unstructured":"Sztechman, D., Czarzasta, K., Cudnoch-Jedrzejewska, A., Szczepanska-Sadowska, E., and Zera, T. (2018). Aldosterone and mineralocorticoid receptors in regulation of the cardiovascular system and pathological remodelling of the heart and arteries. J. Physiol. Pharmacol., 69."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1291\/hypres.27.781","article-title":"Pleiotropic actions of aldosterone and the effects of eplerenone, a selective mineralocorticoid receptor antagonist","volume":"27","author":"Takeda","year":"2004","journal-title":"Hypertens. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/01.HYP.36.4.495","article-title":"Cardiac aldosterone production in genetically hypertensive rats","volume":"36","author":"Takeda","year":"2000","journal-title":"Hypertension"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1210\/jcem.87.8.8731","article-title":"Expression of aldosterone synthase gene in failing human heart: Quantitative analysis using modified real-time polymerase chain reaction","volume":"87","author":"Yoshimura","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1161\/01.CIR.0000142858.44680.27","article-title":"Cardiac specific increase in aldosterone production induces coronary dysfunction in aldosterone synthase-transgenic mice","volume":"110","author":"Garnier","year":"2004","journal-title":"Circulation"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1038\/s41598-017-01882-2","article-title":"Involvement of vascular aldosterone synthase in phosphate-induced osteogenic transformation of vascular smooth muscle cells","volume":"7","author":"Alesutan","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijcard.2018.10.010","article-title":"Evidence of aldosterone synthesis in human myocardium in acute myocarditis","volume":"275","author":"Cardona","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41569-020-0428-2","article-title":"Epidemiology of the inherited cardiomyopathies","volume":"18","author":"McKenna","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev-genom-083118-015306","article-title":"Advances in the genetic basis and pathogenesis of sarcomere cardiomyopathies","volume":"20","author":"Yotti","year":"2019","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1042\/CS20180276","article-title":"Modulation of the renin-angiotensin-system in white aduoise tissue abd skeletal muscle: Forcus on exercise training","volume":"132","author":"Frantz","year":"2018","journal-title":"Clin. Sci."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ace2\/angiotensin-(1-7)\/mas axis of the renin-angiotensin system: Focus on angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","article-title":"Role of the ace2\/angiotensin 1-7 axis of the renin-angiotensin system in heart failure","volume":"118","author":"Patel","year":"2016","journal-title":"Circ. Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4161\/epi.6.4.14961","article-title":"Epigenetic regulation of somatic angiotensin-converting enzyme by DNA methylation and histone acetylation","volume":"6","author":"Lienhard","year":"2011","journal-title":"Epigenetics"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Mudersbach, T., Siuda, D., Kohlstedt, K., and Fleming, I. (2019). Epigenetic control of the angiotensin-converting enzyme in endothelial cells during inflammation. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0216218"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psyneuen.2017.11.003","article-title":"DNA methylation and genetic variation of the angiotensin converting enzyme (ACE) in depression","volume":"88","author":"Lam","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Burford, N.G., Webster, N.A., and Cruz-Topete, D. (2017). Hypothalamic-pituitary-adrenal axis modulation of glucocorticoids in the cardiovascular System. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18102150"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/9\/4587\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:53:23Z","timestamp":1760162003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/9\/4587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,27]]},"references-count":112,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["ijms22094587"],"URL":"https:\/\/doi.org\/10.3390\/ijms22094587","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,27]]}}}